SLC30A9 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.431600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.317210E-01
Normal-vs-Stage2
6.054600E-01
Normal-vs-Stage3
6.730200E-01
Normal-vs-Stage4
2.713200E-01
Stage1-vs-Stage2
8.323800E-02
Stage1-vs-Stage3
4.015900E-02
Stage1-vs-Stage4
8.910600E-01
Stage2-vs-Stage3
2.610400E-01
Stage2-vs-Stage4
1.101440E-01
Stage3-vs-Stage4
1.266050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.520000E-01
Normal-vs-AfricanAmerican
3.640600E-01
Normal-vs-Asian
9.610400E-01
Caucasian-vs-AfricanAmerican
4.639400E-01
Caucasian-vs-Asian
3.015800E-01
AfricanAmerican-vs-Asian
1.908400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.914600E-01
Normal-vs-Female
4.982800E-01
Male-vs-Female
3.668800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.433600E-01
Normal-vs-Age(41-60Yrs)
3.177000E-01
Normal-vs-Age(61-80Yrs)
6.652000E-01
Normal-vs-Age(81-100Yrs)
8.405200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.159000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.415000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.989800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.378300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.194450E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.203200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.624800E-01
Normal-vs-Daily Drinker
9.178800E-01
Normal-vs-Weekly Drinker
8.979400E-01
Normal-vs-Occasional Drinker
2.920200E-01
Normal-vs-Social Drinker
5.335600E-01
Non Drinker-vs-Daily Drinker
6.574800E-01
Non Drinker-vs-Weekly Drinker
7.680000E-01
Non Drinker-vs-Occasional Drinker
5.302300E-02
Non Drinker-vs-Social Drinker
3.293000E-01
Daily Drinker-vs-Weekly Drinker
9.413000E-01
Daily Drinker-vs-Occasional Drinker
3.060500E-02
Daily Drinker-vs-Social Drinker
2.313200E-01
Weekly Drinker-vs-Occasional Drinker
6.383900E-02
Weekly Drinker-vs-Social Drinker
2.868200E-01
Occasional Drinker-vs-Social Drinker
5.520200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.910200E-01
Normal-vs-Grade 2
6.855800E-01
Normal-vs-Grade 3
1.708810E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.036400E-01
Grade 1-vs-Grade 3
7.529800E-01
Grade 1-vs-Grade 4
3.910200E-01
Grade 2-vs-Grade 3
3.141000E-01
Grade 2-vs-Grade 4
6.855800E-01
Grade 3-vs-Grade 4
1.708810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.053600E-01
Normal-vs-NonDiabetic
5.636800E-01
Diabetic-vs-NonDiabetic
1.198390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.693400E-01
Normal-vs-NoPancreatitis
6.002400E-01
Pancreatitis-vs-NoPancreatitis
2.143800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.474200E-01
Normal-vs-N1
5.926200E-01
N0-vs-N1
1.218970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.384800E-01
Normal-vs-TP53-NonMutant
3.800600E-01
TP53-Mutant-vs-TP53-NonMutant
8.440800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
